Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
To address this therapeutic gap, we have developed MEDI4166, a novel glucagon-like peptide-1 (GLP-1) receptor agonist peptide fused to a proprotein convertase subtilisin/kexin type 9 (PCSK9) neutralising antibody that allows for glycaemic control and low-density lipoprotein cholesterol (LDL-C) lowering in a single molecule
We ensure safe, compliant sourcing directly from Japan to your doorstep
The medication comes in multiple packages include: four syringes per carton (NDC:0002-1433-80), one syringe per package, prefilled biologic delivery system (NDC:0002-1433-01), and two syringes per carton (NDC:0002-1433-61)
GLP-1 receptors exist throughout the digestive tract, not just in the stomach
US$ 20.07
US$ 25.96
US$ 24.80
US$ 27.45
US$ 23.31
